AAAAAA
Results:
1-15
|
Results: 15
Authors:
Kikumori, T
Cote, GJ
Gagel, RF
Citation: T. Kikumori et al., Promiscuity of pre-mRNA spliceosome-mediated trans splicing: A problem forgene therapy?, HUM GENE TH, 12(11), 2001, pp. 1429-1441
Authors:
Thomas, PM
Nasonkin, I
Zhang, HQ
Gagel, RF
Cote, GJ
Citation: Pm. Thomas et al., Structure of the mouse calcitonin/calcitonin gene-related peptide alpha and beta genes, DNA SEQ, 12(2), 2001, pp. 131-135
Authors:
Zhang, LP
Hoff, AO
Wimalawansa, SJ
Cote, GJ
Gagel, RF
Westlund, KN
Citation: Lp. Zhang et al., Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity, PAIN, 89(2-3), 2001, pp. 265-273
Authors:
Wohllk, N
Becker, P
Youlton, R
Cote, GJ
Gagel, RF
Citation: N. Wohllk et al., Germline mutations of the ret proto-oncogen in Chilean patients with hereditary and sporadic medullary thyroid carcinoma, REV MED CHI, 129(7), 2001, pp. 713-718
Authors:
Hoff, AO
Cote, GJ
Gagel, RF
Citation: Ao. Hoff et al., Multiple endocrine neoplasias, ANN R PHYSL, 62, 2000, pp. 377-411
Authors:
Jin, W
McCutcheon, IE
Fuller, GN
Huang, ESC
Cote, GJ
Citation: W. Jin et al., Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors, CANCER RES, 60(5), 2000, pp. 1221-1224
Authors:
Dang, GT
Cote, GJ
Schultz, PN
Khorana, S
Decker, RA
Gagel, RF
Citation: Gt. Dang et al., A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy, MOL CELL PR, 13(1), 1999, pp. 77-79
Authors:
Dackiw, APB
Cote, GJ
Fleming, JB
Schultz, PN
Stanford, P
Vassilopoulou-Sellin, R
Evans, DB
Gagel, RF
Lee, JE
Citation: Apb. Dackiw et al., Screening for MEN1 mutations in patients with atypical endocrine neoplasia, SURGERY, 126(6), 1999, pp. 1097-1103
Authors:
Jin, W
Huang, ESC
Bi, WQ
Cote, GJ
Citation: W. Jin et al., Redundant intronic repressors function to inhibit fibroblast growth factorreceptor-1 alpha-exon recognition in glioblastoma cells, J BIOL CHEM, 274(39), 1999, pp. 28035-28041
Authors:
Otonkoski, T
Ammala, C
Huopio, H
Cote, GJ
Chapman, J
Cosgrove, K
Ashfield, R
Huang, E
Komulainen, J
Ashcroft, FM
Dunne, MJ
Kere, J
Thomas, PM
Citation: T. Otonkoski et al., A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland, DIABETES, 48(2), 1999, pp. 408-415
Authors:
Jin, W
Bi, WQ
Huang, ESC
Cote, GJ
Citation: W. Jin et al., Glioblastoma cell-specific expression of fibroblast growth factor receptor-1 beta requires an intronic repressor of RNA splicing, CANCER RES, 59(2), 1999, pp. 316-319
Authors:
Parthasarathy, R
Cote, GJ
Gagel, RF
Citation: R. Parthasarathy et al., Hammerhead ribozyme-mediated inactivation of mutant RET in medullary thyroid carcinoma, CANCER RES, 59(16), 1999, pp. 3911-3914
Authors:
Fleming, JB
Lee, JE
Bouvet, M
Schultz, PN
Sherman, SI
Sellin, RV
Friend, KE
Burgess, MA
Cote, GJ
Gagel, RF
Evans, DB
Citation: Jb. Fleming et al., Surgical strategy for the treatment of medullary thyroid carcinoma, ANN SURG, 230(5), 1999, pp. 697-707
Authors:
Wohllk, N
Thomas, PM
Huang, E
Cote, GJ
Citation: N. Wohllk et al., A human succinate-ubiquinone oxidoreductase CII-3 subunit gene ending in apolymorphic dinucleotide repeat is located within the sulfonylurea receptor (SUR) gene, MOL GEN MET, 65(3), 1998, pp. 187-190
Authors:
Gagel, RF
Cote, GJ
Citation: Rf. Gagel et Gj. Cote, Pathogenesis of medullary thyroid carcinoma, ENDOC UPD S, 2, 1998, pp. 85-103
Risultati:
1-15
|